Systematical evaluation of the effects of sample collection procedures on low‐molecular‐weight serum/plasma proteome profiling
暂无分享,去创建一个
Sen-Yung Hsieh | S. Hsieh | Ren-Kung Chen | Yi-Hsin Pan | Hai-Lun Lee | Yi-Hsin Pan | Ren-Kung Chen | Hai-Lun Lee
[1] Rob Pieters,et al. Identification of Tumor‐Related Proteins by Proteomic Analysis of Cerebrospinal Fluid from Patients with Primary Brain Tumors , 2003, Journal of neuropathology and experimental neurology.
[2] S. Hanash. Disease proteomics : Proteomics , 2003 .
[3] I. Jacobs,et al. Screening for ovarian cancer , 1999, The Lancet.
[4] J. White. EDTA-induced changes in platelet structure and function: clot retraction , 2000, Platelets.
[5] Hongyu Zhao,et al. Serum protein markers for early detection of ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] Graham B. I. Scott,et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.
[7] M. Kostrzewa,et al. Mass spectrometry-based clinical proteomics. , 2003, Pharmacogenomics.
[8] Michael J Campa,et al. Identification and validation of a potential lung cancer serum biomarker detected by matrix‐assisted laser desorption/ionization‐time of flight spectra analysis , 2003, Proteomics.
[9] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[10] Ralf Ketterlinus,et al. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. , 2005, BioTechniques.
[11] Weimin Zhu,et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. , 2003, Journal of proteome research.
[12] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[13] T. Yip,et al. Synthetic metal-binding protein surface domains for metal ion-dependent interaction chromatography. I. Analysis of bound metal ions by matrix-assisted UV laser desorption time-of-flight mass spectrometry. , 1992, Journal of chromatography.
[14] Fang Wang,et al. The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteins , 2003, Proteomics.
[15] S. Baumann,et al. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2005, Clinical chemistry.
[16] D. Chan,et al. Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry , 2004, Clinical Cancer Research.
[17] M. Ferrari,et al. Clinical proteomics: Written in blood , 2003, Nature.
[18] E. Holland,et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.
[19] Ronald J. Moore,et al. Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.
[20] P. Ludbrook,et al. Sustained Fibrinolysis After Administration of t-PA Despite Its Short Half-Life in the Circulation , 1987, Thrombosis and Haemostasis.
[21] P. Schellhammer,et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.
[22] J. Barrett,et al. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. , 2005, Clinical chemistry.
[23] K. Spencer. The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system , 2003, Annals of clinical biochemistry.
[24] D. Hochstrasser,et al. A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt‐Jakob disease , 2003, Proteomics.
[25] E. Petricoin,et al. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. , 2004, Current opinion in biotechnology.
[26] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.
[27] E. Diamandis. Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool , 2004, Molecular & Cellular Proteomics.
[28] Douglas C Pearl,et al. Proteomic patterns in serum and identification of ovarian cancer , 2002, The Lancet.